Fosun Pharmaceuticals 4.4 billion fixed increase, Gao Yi Assets, which was bought in 2 billion yuan, became the third largest shareholder of the company

On the evening of July 26, Fosun Pharmaceutical (SH600196, the stock price of 47.42 yuan, and a market value of 121.533 billion yuan) announced the "Report on the Issuance of A shares of A shares in non -public issuance". 42.00 yuan/share, the net fundraising fund is 4.456 billion yuan.

"Daily Economic News" reporter noticed that the 10 issues of the final determined issuance of Fosun Pharmaceutical's non -public distribution can be described as shining. Among them, the well -known fund manager Feng Liu's Gao Yishan No. 1 Yuanwang Fund was ranked first in the list, with a amount of nearly 2 billion yuan. In addition, Caitong Fund, Huaxia Fund, CITIC Securities, Huatai Securities, China Merchants Fund Waiting for well -known institutions are also among them.

Photo source: Fosun Pharmaceutical Announcement Screenshot

After the completion of the fixed increase, Feng Liu's Gao Yishan No. 1 Yuanwang Fund, UBS AG, and Caitong Fund Management Co., Ltd. will be newly entered into the third, sixth, and ninth shareholders of Fosun Pharmaceutical. The share ratio reached 1.78%, 0.75%, and 0.51%, respectively. Shanghai Fosun High Technology (Group) Co., Ltd. and HKSCC NOMINEES LIMITED are still the major shareholders with a shareholding of more than 5%of Fosun Pharmaceutical's only shareholding; And 20.65%.

In response to the impact of this fixed increase on the company's business structure, Fosun Pharmaceutical stated in the announcement that the investment project raised funds investment projects revolved around the development strategic layout of the issuer group, which is related to the high degree of business business of the issuer's group, including for innovation, including innovation Drugs clinical, licensed introduction and product listing related preparation projects, raw drugs and preparation intensive comprehensive base projects and supplementary funds.

On July 26, Fosun Pharmaceutical closed at 47.42 yuan. Based on the price, the fixed -income institution has been floating by 12.90%, and Gao Yi's neighboring mountain No. 1 Yuanwang Fund floats about 258 million yuan.

Daily Economic News

- END -